Newsroom

News

Between July 2020 and August 2021, the Epidemiology Department of the Helmholtz Centre for Infection Research (HZI) in Braunschweig examined the blood of approximately 26,000 individuals for antibodies against the SARS-CoV-2 coronavirus as part of the nationwide “MuSPAD” study. For samples collected between July and October 2020, it became evident that one to three per cent of the people had experienced a SARS-CoV-2 infection after the first wave. By the end of the third wave, the seroprevalence had increased but remained at less than 15 per cent at most study sites. Therefore, while there were two to five actual infections for every reported infection during the first wave, this ratio - and thus the number of undetected cases - decreased in the second and third waves. These results were recently published in the international issue of Deutsches Ärzteblatt. In addition, a preprint publication of another study investigating the immune response after vaccination against SARS-CoV-2 based on samples from the MuSPAD study is under review.

08.12.2021

HZI Campus

Interview

A conversation about the direction of research at the HZI with Prof Thomas Pietschmann, who is the head of the "Experimental Virology" department at the HZI and director of the Experimental Virology Institute at the TWINCORE - Centre for Experimental and Clinical Infection Research

06.12.2021

TWINCORE

Interview

The cold season has arrived along with the question of whether a vaccination against influenza makes sense in times of the ongoing pandemic. And when is the right time for the third vaccination, i.e. the booster vaccination against Covid-19?

03.12.2021

HZI Campus

News

On the occasion of its 15th anniversary, the MTZ®foundation presented the SonderMTZ®-Award 2021 in Erkrath-Trills. The award winner is Dr Sahamoddin Khailaie from the department "Systems Immunology" headed by Prof Michael Meyer-Hermann at the Helmholtz Centre for Infection Research (HZI) in Braunschweig. The prize was awarded in recognition of his outstanding achievements in the field of Medical Systems Biology and Systems Medicine. The award ceremony took place during the 13th PhD Symposium of the HZI on 2 December 2021.

03.12.2021

BRICS

News

Cholesterol-lowering drugs do not promote infection with the novel coronavirus SARS-CoV-2. This is the conclusion of a team of researchers from TWINCORE - Center for Experimental and Clinical Infection Research and the University of Veterinary Medicine Hannover Foundation, led by Prof Gisa Gerold, together with colleagues from the Helmholtz Centre for Infection Research (HZI) in Braunschweig and Umea University in Sweden. The scientists have studied several lipid-lowering agents from the group of statins in a cell culture model. They have now published their results in the journal iScience. The TWINCORE-Centre for Experimental and Clinical Infection Research is a joint institution of the Hannover MEdical School (MHH) and the HZI.

03.12.2021

HZI Campus

TWINCORE

News

Salmonella enterica, a foodborne pathogen, is one of four key global causes of diarrheal diseases, which affect over 550 million people each year. This rod-shaped, Gram-negative bacterium has tubular, whip-like appendages known as flagella that protrude from its surface. Researchers from the Centre for Structural Systems Biology (CSSB) in collaboration with researchers at Research Center Borstel FZB, as well as Max Plank Institute for Infection Biology, the University of Marburg and the Technische Universität Braunschweig studied biochemical and biophysical properties of these bacterial structures. Their study was recently published in PLoS Pathogens. The CSSB is a common initiative by ten northern German research institutions, including the Helmholtz Centre for Infection Research (HZI) in Braunschweig.

03.12.2021

CSSB

Back to the first page
...
48
49
50
51
...
149

HZI in the media

s drug tolcapone. HIPS is a site of the Helmholtz Center for Infection Research (HZI) in collaboration with Saarland University.

The

26.11.2025

Medical Xpress

... erhielt das Projekt „Citrapeutics“ vom Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig eine Förderung in Höhe ...

25.11.2025

Bionity.COM

led by Hannover Medical School (MHH) and the Helmholtz Center for Infection Research (HZI) has now discovered clear molecular signatures for

24.11.2025

Medical Xpress

Medizinischen Hochschule Hannover (MHH) und dem Helmholtz-Zentrum für Infektionsforschung (HZI), hat nun eindeutige molekulare Signaturen ...

24.11.2025

DeutschesGesundheitsPortal

Braunschweig. Das Helmholtz-Zentrum für Infektionsforschung (HZI) bringt anlässlich seines 60. Jubiläums seine Forschung vom 3. ...

22.11.2025

Regional Heute

Universität Hannover (LUH), dem Helmholtz Zentrum für Infektionsforschung (HZI) in Braunschweig, der Technischen Universität Braunschweig ...

21.11.2025

Medizinische Hochschule Hannover

... 38100 Braunschweig Das Helmholtz-Zentrum für Infektionsforschung: Wissenschaftler:innen am Helmholtz-Zentrum für Infektionsforschung ( ...

20.11.2025

Bochumer-Zeitung

Dr. Dunja Bruder ist Forschungsgruppenleiterin am Helmholtz-Zentrum für Infektionsforschung in Braunschweig und zugleich Professorin für

20.11.2025

Bilanz

... Wissenschaftler und Wissenschaftlerinnen des Helmholtz-Zentrums für Infektionsforschung (HZI) und der Medizinischen Hochschule ...

19.11.2025

Rheinische Post

... Forschungsschwerpunkt „Neue Antiinfektiva“ des Helmholtz-Zentrums für Infektionsforschung (HZI) entwickeln fast 20 Forschungsgruppen neue ...

18.11.2025

Regional Heute

... , Stellvertretende Teamleiterin der Klinischen Epidemiologie am Helmholtz-Zentrum für Infektionsforschung (HZI), Braunschweig.

17.11.2025

Biermann Medizin

... und individueller Darmflora ab.

Forscher am Helmholtz-Zentrum für Infektionsforschung arbeiten bereits an der nächsten Generation ...

14.11.2025

Ad Hoc News

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.